Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!
|Name of ready to use
|K283||Human Molecular marker for hematopoiesis supportive function (single check): Granulocyte-macrophage stimulating factor (M-CSF)||-20°C||100||199,-€|